Patent · US Active

Vaccine for falciparum malaria

US10213502B2 · kind B2 · utility

3Cited by
0References
7Claims
0Family size

Assignees

Inventors

Key dates

Filing dateMay 26, 2017
Grant dateFeb 26, 2019
Priority date—
Expiry dateMay 26, 2037

Classification

  • Technology area (CPC Y)Emerging Cross-Sectional Technologies
  • CPC primaryY02A50/30
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The invention provides compositions and methods for preventing or reducing the severity of malaria.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.